Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress 2022-03-15 00:06
MediLink Therapeutics closes US$70 million Series B financing 2022-03-14 20:50
NuclixBio Announces a Collaborative Research Agreement with PharmAbcine 2022-03-14 20:00
111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits 2022-03-14 19:35
Hexvix® Has Obtained CDE Approval for the Inclusion In the Clinical Real-world Evidence Pilot Study 2022-03-14 14:25
Impact Therapeutics Announces Completion of Series D1 Financing 2022-03-14 12:43
THE WORLD'S FIRST ACADEMIC PAPER ON THE POTENTIAL USE OF VIRTUAL REALITY IN MODULATING PSYCHEDELIC-ASSISTED PSYCHOTHERAPY PUBLISHED BY THE CO-FOUNDERS OF ENOSIS THERAPEUTICS 2022-03-10 21:00
Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO 2022-03-10 20:00
Artificial Retinal Device Mimics Human Optical Illusions: WPI-MANA 2022-03-10 16:00
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting 2022-03-10 07:00
English Version of Hands-On Medical VR Developed. Exhibiting At SXSW 2022. 2022-03-09 21:00
I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-03-09 21:00
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022 2022-03-09 07:47
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer 2022-03-09 06:58
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022 2022-03-09 05:30
Akeso Announces IND Approval from China NMPA for Phase II Clinical Trial of Cadonilimab in Combination with Docetaxel to Treat NSCLC 2022-03-08 11:49
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies 2022-03-08 08:00
Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases 2022-03-08 08:00
Singleron Acquires Proteona 2022-03-07 23:00
Alterity Therapeutics to Present at the 34th Annual Roth Conference 2022-03-07 20:59
1 137 138 139 140 141 432